Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Sell
45,606
-110,192
-71% -$3.58M 0.17% 185
2025
Q4
$5.1M Buy
+155,798
New +$3.83M 0.57% 66
2025
Q2
Sell
-240,737
Closed -$4.45M 239
2025
Q1
$4.45M Buy
240,737
+204,190
+559% +$3.68M 0.77% 26
2024
Q4
$602K Sell
36,547
-33,529
-48% -$475K 0.09% 243
2024
Q3
$982K Buy
+70,076
New +$775K 0.15% 167
2023
Q1
Sell
-110,252
Closed -$1.1M 260
2022
Q4
$1.1M Sell
110,252
-28,520
-21% -$317K 0.23% 210
2022
Q3
$1.65M Buy
+138,772
New +$1.39M 0.36% 120
2018
Q3
Sell
-75,926
Closed -$3.81M 302
2018
Q2
$3.81M Sell
75,926
-44,127
-37% -$1.94M 0.6% 36
2018
Q1
$4.38M Sell
120,053
-43,128
-26% -$1.32M 0.73% 12
2017
Q4
$4.62M Sell
163,181
-128,387
-44% -$3.03M 0.83% 5
2017
Q3
$5.64M Sell
291,568
-2,312
-0.8% -$38.8K 0.75% 11
2017
Q2
$4.92M Buy
293,880
+136,453
+87% +$1.84M 0.81% 7
2017
Q1
$1.65M Sell
157,427
-152,513
-49% -$1.56M 0.26% 160
2016
Q4
$2.79M Sell
309,940
-61,537
-17% -$530K 0.37% 136
2016
Q3
$3.35M Buy
371,477
+52,999
+17% +$431K 0.45% 60
2016
Q2
$2.19M Hold
318,478
0.33% 167
2016
Q1
$1.71M Sell
318,478
-11,260
-3% -$57.2K 0.27% 170
2015
Q4
$1.65M Buy
329,738
+1,298
+0.4% +$6.42K 0.22% 189
2015
Q3
$1.35M Buy
+328,440
New +$1.32M 0.21% 217

Other funds holding AXGN

EAM Investors's AXGN Position: Q1 2026 in Review

EAM Investors reduced its Axogen (AXGN) stake by 71% in Q1 2026, selling an estimated $3.58M and leaving 45,606 shares worth $1.51M. The position accounts for 0.17% of the portfolio, ranked #185.

EAM Investors first reported a position in AXGN in Q3 2015 and has held it in 19 quarters since. The position peaked at $5.64M in Q3 2017. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • EAM Investors held 45,606 shares of Axogen worth $1.51M as of Q1 2026.
  • EAM Investors sold 110,192 Axogen shares in Q1 2026, an estimated $3.58M.
  • Axogen made up 0.17% of EAM Investors's portfolio in Q1 2026, its #185 holding.
  • EAM Investors first reported a position in Axogen in Q3 2015 and has held it in 19 quarters since.
  • EAM Investors's Axogen position peaked at $5.64M in Q3 2017.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.